Echo Street Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-217,492
| Closed | -$110M | – | 383 |
|
|
2023
Q3 | $110M | Sell |
217,492
-1,129
| -0.5% | -$602K | 1.03% | 39 |
|
|
2023
Q2 | $114M | Sell |
218,621
-116,892
| -35% | -$63.1M | 0.98% | 42 |
|
|
2023
Q1 | $193M | Buy |
335,513
+77,467
| +30% | +$43.7M | 1.74% | 17 |
|
|
2022
Q4 | $142M | Sell |
258,046
-69,052
| -21% | -$36.6M | 1.38% | 29 |
|
|
2022
Q3 | $166M | Buy |
327,098
+3,981
| +1% | +$2.23M | 1.59% | 15 |
|
|
2022
Q2 | $176M | Buy |
323,117
+2,525
| +0.8% | +$1.39M | 1.59% | 11 |
|
|
2022
Q1 | $189M | Sell |
320,592
-29,715
| -8% | -$17.1M | 1.36% | 18 |
|
|
2021
Q4 | $234M | Sell |
350,307
-101,127
| -22% | -$63.1M | 1.57% | 8 |
|
|
2021
Q3 | $258M | Sell |
451,434
-5,702
| -1% | -$3.13M | 1.81% | 3 |
|
|
2021
Q2 | $231M | Buy |
457,136
+121,418
| +36% | +$57.3M | 1.78% | 3 |
|
|
2021
Q1 | $153M | Buy |
335,718
+40,304
| +14% | +$19.2M | 1.37% | 17 |
|
|
2020
Q4 | $138M | Buy |
295,414
+50,684
| +21% | +$23.8M | 1.38% | 15 |
|
|
2020
Q3 | $108M | Sell |
244,730
-104,420
| -30% | -$43.1M | 1.86% | 7 |
|
|
2020
Q2 | $127M | Buy |
349,150
+71,932
| +26% | +$24.1M | 1.5% | 8 |
|
|
2020
Q1 | $78.6M | Buy |
277,218
+83,378
| +43% | +$26.3M | 1.69% | 10 |
|
|
2019
Q4 | $63M | Sell |
193,840
-56,960
| -23% | -$17.3M | 0.97% | 31 |
|
|
2019
Q3 | $73.1M | Buy |
250,800
+33,207
| +15% | +$9.51M | 1.24% | 16 |
|
|
2019
Q2 | $63.9M | Buy |
217,593
+51,457
| +31% | +$14.2M | 1.13% | 25 |
|
|
2019
Q1 | $45.5M | Sell |
166,136
-82,888
| -33% | -$20.6M | 0.89% | 33 |
|
|
2018
Q4 | $55.7M | Sell |
249,024
-8,786
| -3% | -$2.06M | 1.41% | 15 |
|
|
2018
Q3 | $62.9M | Sell |
257,810
-80,492
| -24% | -$18.5M | 1.39% | 10 |
|
|
2018
Q2 | $70.1M | Buy |
338,302
+97,979
| +41% | +$20.8M | 1.71% | 8 |
|
|
2018
Q1 | $49.6M | Sell |
240,323
-7,069
| -3% | -$1.48M | 1.45% | 17 |
|
|
2017
Q4 | $47M | Buy |
247,392
+109,838
| +80% | +$21M | 1.42% | 15 |
|
|
2017
Q3 | $26M | Sell |
137,554
-62,006
| -31% | -$11.2M | 0.89% | 36 |
|
|
2017
Q2 | $34.8M | Buy |
199,560
+11,092
| +6% | +$1.86M | 1.29% | 20 |
|
|
2017
Q1 | $28.9M | Buy |
188,468
+114,987
| +156% | +$17.6M | 0.97% | 27 |
|
|
2016
Q4 | $10.4M | Sell |
73,481
-51,707
| -41% | -$7.62M | 0.41% | 83 |
|
|
2016
Q3 | $19.9M | Buy |
125,188
+6,693
| +6% | +$1.03M | 0.84% | 40 |
|
|
2016
Q2 | $17.5M | Sell |
118,495
-47,109
| -28% | -$6.95M | 0.73% | 44 |
|
|
2016
Q1 | $23.4M | Buy |
165,604
+100,450
| +154% | +$13.5M | 1.22% | 20 |
|
|
2015
Q4 | $9.24M | Sell |
65,154
-326,507
| -83% | -$43.5M | 0.4% | 82 |
|
|
2015
Q3 | $47.9M | Buy |
391,661
+110,684
| +39% | +$14.4M | 1.76% | 8 |
|
|
2015
Q2 | $36.5M | Buy |
280,977
+233,883
| +497% | +$30.5M | 1.61% | 16 |
|
|
2015
Q1 | $6.33M | Sell |
47,094
-119,289
| -72% | -$15.4M | 0.37% | 82 |
|
|
2014
Q4 | $20.8M | Buy |
166,383
+7,450
| +5% | +$906K | 1.29% | 26 |
|
|
2014
Q3 | $19.3M | Buy |
158,933
+16,309
| +11% | +$1.98M | 1.12% | 29 |
|
|
2014
Q2 | $16.8M | Buy |
142,624
+71,285
| +100% | +$8.39M | 1.1% | 30 |
|
|
2014
Q1 | $8.58M | Sell |
71,339
-85,595
| -55% | -$10.2M | 0.67% | 48 |
|
|
2013
Q4 | $17.5M | Buy |
+156,934
| New | +$15.6M | 1.71% | 23 |
|
Other funds holding TMO
Echo Street Capital Management's TMO Position: Q4 2023 in Review
Echo Street Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 217,492 shares — an estimated $110M sold.
Echo Street Capital Management first reported a position in TMO in Q4 2013 and held it in 40 quarters. The position peaked at $258M in Q3 2021. 2,488 funds tracked by Wall St. Rank hold TMO as of Q4 2023.
- Echo Street Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
- Echo Street Capital Management sold 217,492 Thermo Fisher Scientific shares in Q4 2023, an estimated $110M.
- Echo Street Capital Management first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 40 quarters.
- Echo Street Capital Management's Thermo Fisher Scientific position peaked at $258M in Q3 2021.
- 2,488 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.
Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.